Výsledky vyhledávání - "GlE/PIB"

Impact of HCV eradication by directly acting antivirals on glycemic indices in chronic hepatitis C patients -a nationwide Taiwan HCV registry

Autoři: Tyng-Yuan Jang Chung-Feng Huang Te-Sheng Chang a další

Zdroj: Journal of the Formosan Medical Association, Vol 124, Iss 8, Pp 731-737 (2025)

Témata: Medicine (General), HbA1c, SVR, R5-920, Hepacivirus, GlE/PIB, Hepatitis C, DAA

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39168745
https://doaj.org/article/894fafa8087949f9bdcf81f9e67c7b97

Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter study

Autoři: Atsuhiro Morita Nobuharu Tamaki Haruhiko Kobashi a další

Zdroj: JGH Open
JGH Open, Vol 8, Iss 4, Pp n/a-n/a (2024)

Témata: 0301 basic medicine, glecaprevir and pibrentasvir (GLE/PIB), 0303 health sciences, 03 medical and health sciences, treatment periods, cirrhosis, chronic hepatitis C, RC799-869, Original Articles, Diseases of the digestive system. Gastroenterology, 3. Good health

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38681824
https://doaj.org/article/0d9873a1fd55472ea90b8aee2ad5fcad

Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

Autoři: Aghemo A Alberti A Andreone P a další

Přispěvatelé: Aghemo A Alberti A Andreone P a další

Zdroj: Digestive and Liver Disease. 53:612-619

Témata: Adult, Male, 0301 basic medicine, Pyrrolidines, Sustained Virologic Response, elderly, Antiviral Agents, GLE/PIB, 03 medical and health sciences, Elderly, HCV, PWUD, Quinoxalines, Product Surveillance, Postmarketing, Humans, Prospective Studies, Aged, Benzimidazoles, Drug Combinations, Hepatitis C, Chronic, Quality of Life, Sulfonamides, 0303 health sciences, Middle Aged, 3. Good health, Italy, Female

Popis souboru: application/pdf; ELETTRONICO; STAMPA

Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/32917546
http://hdl.handle.net/11588/823915
https://www.ncbi.nlm.nih.gov/pubmed/32917546
https://www.sciencedirect.com/science/article/pii/S1590865820304011
https://iris.unimore.it/handle/11380/1227437
https://pubmed.ncbi.nlm.nih.gov/32917546/
https://moh-it.pure.elsevier.com/en/publications/effectiveness-and-safety-of-glecaprevirpibrentasvir-in-chronic-he
https://hdl.handle.net/10281/352603
https://doi.org/10.1016/j.dld.2020.08.007
https://hdl.handle.net/10807/204846
https://doi.org/10.1016/j.dld.2020.08.007
https://hdl.handle.net/10447/535598
https://doi.org/10.1016/j.dld.2020.08.007
https://hdl.handle.net/11584/299570
https://doi.org/10.1016/j.dld.2020.08.007
https://hdl.handle.net/11568/1065599
https://doi.org/10.1016/j.dld.2020.08.007
https://hdl.handle.net/11588/823915
https://doi.org/10.1016/j.dld.2020.08.007
https://hdl.handle.net/11570/3188794
https://doi.org/10.1016/j.dld.2020.08.007

Drug pricing for hepatitis B and C in Australia and Japan.

Autoři: Suoh, Maito Esmaili, Saeed Eslam, Mohammed a další

Zdroj: Ann Hepatol ; ISSN:1665-2681

Témata: Abbreviations: ADF, adefovir, ETV, entecavir, GLE/PIB, glecaprevir/pibrentasvir, HBV, hepatitis B virus, HCV, hepatitis C virus, JPY, Japanese yen, LAM, lamivudine, NA, nucleoside/nucleotide analogue, Peg-IFN, pegylated interferon, SOF/LDV, sofosbuvir/ledipasvir, SOF/VEL, sofosbuvir/velpatasvir, TAF, tenofovir alafenamide, TDF, tenofovir disoproxil fumarate, USD, United States dollar

Relation: https://doi.org/10.1016/j.aohep.2025.102118; https://pubmed.ncbi.nlm.nih.gov/40992626

Dostupnost: https://doi.org/10.1016/j.aohep.2025.102118
https://pubmed.ncbi.nlm.nih.gov/40992626

Consideration of ledipasvir/sofosbuvir as an alternative to glecaprevir/pibrentasvir based upon on-treatment FIB-4 changes and sustained virologic response at 12 weeks in hepatitis C genotype 1 and 2 infections: A propensity score-matched study.

Autoři: Park HJ Wang H Jeong J a další

Zdroj: Medicine [Medicine (Baltimore)] 2025 Nov 21; Vol. 104 (47), pp. e46079.

Způsob vydávání: Journal Article; Observational Study; Comparative Study

Informace o časopise: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

Výrazy ze slovníku MeSH: Benzimidazoles*/therapeutic use , Benzimidazoles*/administration & dosage , Sofosbuvir*/therapeutic use , Sofosbuvir*/administration & dosage , Quinoxalines*/therapeutic use , Quinoxalines*/administration & dosage , Antiviral Agents*/therapeutic use , Antiviral Agents*/administration & dosage , Fluorenes*/therapeutic use , Fluorenes*/administration & dosage , Sulfonamides*/therapeutic use , Sulfonamides*/administration & dosage , Hepatitis C, Chronic*/drug therapy , Hepatitis C, Chronic*/virology , Uridine Monophosphate*/analogs & derivatives , Uridine Monophosphate*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Propensity Score ; Sustained Virologic Response ; Hepacivirus/genetics ; Pyrrolidines ; Cyclopropanes ; Leucine/analogs & derivatives ; Genotype ; Adult ; Aged ; Drug Combinations ; Proline/analogs & derivatives ; Aminoisobutyric Acids ; Lactams, Macrocyclic ; Retrospective Studies ; Drug Therapy, Combination

Glecaprevir/Pibrentasvir Versus Sofosbuvir/Velpatasvir for Hepatitis C Virus Genotype 6: A Systematic Review and Meta-Analysis.

Autoři: Le DHH Nguyen DC Kanokudom S a další

Zdroj: Reviews in medical virology [Rev Med Virol] 2025 Nov; Vol. 35 (6), pp. e70074.

Způsob vydávání: Comparative Study; Journal Article; Meta-Analysis; Systematic Review

Informace o časopise: Publisher: Wiley Country of Publication: England NLM ID: 9112448 Publication Model: Print Cited Medium: Internet ISSN: 1099-1654 (Electronic) Linking ISSN: 10529276 NLM ISO Abbreviation: Rev Med Virol Subsets: MEDLINE

Výrazy ze slovníku MeSH: Antiviral Agents*/therapeutic use , Antiviral Agents*/adverse effects , Benzimidazoles*/therapeutic use , Benzimidazoles*/adverse effects , Carbamates*/therapeutic use , Carbamates*/adverse effects , Hepacivirus*/genetics , Hepacivirus*/drug effects , Hepacivirus*/classification , Hepatitis C, Chronic*/drug therapy , Hepatitis C, Chronic*/virology , Heterocyclic Compounds, 4 or More Rings*/therapeutic use , Heterocyclic Compounds, 4 or More Rings*/adverse effects , Quinoxalines*/therapeutic use , Quinoxalines*/adverse effects , Sofosbuvir*/therapeutic use , Sofosbuvir*/adverse effects , Sulfonamides*/therapeutic use , Sulfonamides*/adverse effects, Humans ; Aminoisobutyric Acids ; Drug Combinations ; Genotype ; Leucine/analogs & derivatives ; Leucine/analogs & derivatives ; Proline/analogs & derivatives ; Proline/analogs & derivatives ; Pyrrolidines/therapeutic use ; Sustained Virologic Response ; Treatment Outcome ; Benzopyrans ; Cyclopropanes ; Lactams, Macrocyclic

Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

Autoři: Aghemo, A. Alberti, A. Andreone, P. a další

Témata: elderly, GLE/PIB, HCV, PWUD, Adult, Aged, Antiviral Agents, Benzimidazoles, Drug Combinations, Female, Hepatitis C, Chronic, Humans, Italy, Male, Middle Aged, Product Surveillance, Postmarketing, Prospective Studies, Pyrrolidines, Quality of Life, Quinoxalines, Sulfonamides, Sustained Virologic Response, Settore MED/12 - GASTROENTEROLOGIA, Settore MED/09 - MEDICINA INTERNA, info:eu-repo/semantics/article

URL: http://hdl.handle.net/10807/204846
info:eu-repo/semantics/altIdentifier/pmid/32917546
info:eu-repo/semantics/altIdentifier/wos/WOS:000644954600015
volume:53
issue:5
firstpage:612
lastpage:619
numberofpages:8
issueyear:n/a
journal:DIGESTIVE AND LIVER DISEASE

Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

Autoři: Aghemo, A Alberti, A Andreone, P a další

Témata: elderly, GLE/PIB, HCV, PWUD, info:eu-repo/semantics/article

URL: http://hdl.handle.net/10281/352603
info:eu-repo/semantics/altIdentifier/pmid/32917546
info:eu-repo/semantics/altIdentifier/wos/WOS:000644954600015
volume:53
issue:5 (May 2021)
firstpage:612
lastpage:619
numberofpages:8
journal:DIGESTIVE AND LIVER DISEASE

Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry.

Autoři: Chang TS Huang CF Kuo HT a další

Zdroj: Hepatology international [Hepatol Int] 2023 Jun; Vol. 17 (3), pp. 550-561. Date of Electronic Publication: 2023 Mar 27.

Způsob vydávání: Journal Article

Informace o časopise: Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-0541 (Electronic) Linking ISSN: 19360533 NLM ISO Abbreviation: Hepatol Int Subsets: MEDLINE

Výrazy ze slovníku MeSH: Hepatitis C, Chronic*/complications , Hepatitis C, Chronic*/drug therapy , Hepatitis C, Chronic*/epidemiology, Humans ; Taiwan/epidemiology ; Hepacivirus/genetics ; Liver Cirrhosis/epidemiology ; Sustained Virologic Response ; Quinoxalines/adverse effects ; Antiviral Agents/adverse effects ; Registries ; Proline ; Genotype

Effect of Sofosbuvir/Ledipasvir and Glecaprevir/Pibrentasvir on Serum Creatinine.

Autoři: Amjad W Zhang T Maheshwari A a další

Zdroj: Journal of clinical and experimental hepatology [J Clin Exp Hepatol] 2022 Mar-Apr; Vol. 12 (2), pp. 329-335. Date of Electronic Publication: 2021 Aug 20.

Způsob vydávání: Journal Article

Informace o časopise: Publisher: Elsevier Country of Publication: India NLM ID: 101574137 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0973-6883 (Print) Linking ISSN: 09736883 NLM ISO Abbreviation: J Clin Exp Hepatol Subsets: PubMed not MEDLINE

Cost-effectiveness analysis of glecaprevir/pibrentasvir regimen for treating Chinese patients with chronic hepatitis C genotype 1 and genotype 2 infection.

Autoři: Zhou HJ Wu G Li JM a další

Zdroj: Annals of palliative medicine [Ann Palliat Med] 2021 Oct; Vol. 10 (10), pp. 10313-10326. Date of Electronic Publication: 2021 Sep 22.

Způsob vydávání: Journal Article

Informace o časopise: Publisher: AME Publishing Company Country of Publication: China NLM ID: 101585484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2224-5839 (Electronic) Linking ISSN: 22245820 NLM ISO Abbreviation: Ann Palliat Med Subsets: MEDLINE

Výrazy ze slovníku MeSH: Antiviral Agents*/therapeutic use , Hepatitis C, Chronic*/drug therapy, Adult ; Aminoisobutyric Acids ; Benzimidazoles ; China ; Cost-Benefit Analysis ; Cyclopropanes ; Drug Therapy, Combination ; Genotype ; Humans ; Lactams, Macrocyclic ; Leucine/analogs & derivatives ; Proline/analogs & derivatives ; Pyrrolidines ; Quinoxalines ; Sulfonamides